Home › Non-Hodgkin Lymphoma › Alabama › Birmingham
Non-Hodgkin Lymphoma clinical trials in Birmingham, AL
7 studies for Non-Hodgkin Lymphoma are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- University of Alabama At Birmingham Hospital, Birmingham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Hospital of Alabama, Birmingham
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- University of Alabama at Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Birmingham
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
RecruitingPhase 2
- University of Alabama, Birmingham
Non-Hodgkin Lymphoma trials in other cities
- Houston, TX31 studies
- New York City, NY31 studies
- Boston, MA26 studies
- Nashville, TN21 studies
- Philadelphia, PA20 studies
- Baldwin Park, CA19 studies
- Atlanta, GA18 studies
- Chicago, IL18 studies
- Columbus, OH18 studies
- Milwaukee, WI18 studies
- Washington, DC18 studies
- Dallas, TX17 studies
Other studies in Birmingham
- Cancer (all types)30 studies
- Breast Cancer24 studies
- Obesity23 studies
- Ovarian Cancer23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Overweight16 studies
- Endometrial Cancer16 studies
- Type 2 Diabetes16 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.